Autoimmune disorders, including diseases such as rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes, occur when the body’s immune system mistakenly targets and attacks its own tissues. These disorders are highly complex and often involve a combination of genetic predisposition, environmental factors, and immune dysregulation. Despite significant advances in the understanding of autoimmune diseases, their exact pathogenesis remains unclear, and reliable biomarkers for early diagnosis, disease activity monitoring, and treatment response are still lacking.
Received: 01 October, 2024, Manuscript No. jmbd-25-157284; Editor Assigned: 03 October, 2024, PreQC No. P-157284; Reviewed: 14 October, 2024, QC No. Q-157284; Revised: 21 October, 2024, Manuscript No. R-157284; Published: 28 October, 2024, DOI: 10.37421/2155-9929.2024.15.663.
HTML PDFShare this article
Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report
